TY - JOUR
T1 - Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation
AU - Musial, Jacek
AU - Niewiarowski, Stefan
AU - Hershock, Diane
AU - Morinelli, Thomas A.
AU - Colman, Robert W.
AU - Edmunds, L. Henry
PY - 1985/4
Y1 - 1985/4
N2 - In vitro recirculation of fresh human heparinized blood in an extracorporeal circuit with a membrane oxygenator decreased fibrinogen-induced platelet aggregation and diminished the number of fibrinogen receptors and glycoprotein IIb/IIIa (GPIIb/GPIIIa) antigenic sites on the platelet surface. In seven experiments, the mean ± SD Km velue for fibrinogen (i.e., molar concentration of fibrinogen required to cause 50% of the maximal rate of aggregation) was 1.58 × 10-7mol/L ± 0.68 × 10-7 mol/L. After recirculation, this value increased to 3.8 × 10-7 mol/L ± 1.94 × 10-7 mol/L (P ≤ 0.025). The maximal aggregation rate of chymotrypsin-treated platelets decreased by 40% after 2 hours of recirculation (P ≤ 0.025). The number of fibrinogen receptors on platelets, which were treated with chymotrypsin after recirculation, decreased from 41,370 ± 24,000 to 13,230 ± 10,230/platelet under the same conditions (P ≤ 0.025). The number of antigenic sites for monoclonal antibody reacting with GPIIb/GPIIIa complex of adenosine diphosphate-stimulated platelets decreased from 34,200 ± 5,940 to 19,500 ± 9,680/platelet after recirculation (P ≤ 0.025). Prostaglandin E1 (0.3 μmol/L) in the perfusion circuit preserved the ability of platelets to react with fibrinogen. In conclusion, the loss of fibrinogen receptors from the surface of platelet membranes results from the interaction of platelets with the surfaces of perfusion circuits.
AB - In vitro recirculation of fresh human heparinized blood in an extracorporeal circuit with a membrane oxygenator decreased fibrinogen-induced platelet aggregation and diminished the number of fibrinogen receptors and glycoprotein IIb/IIIa (GPIIb/GPIIIa) antigenic sites on the platelet surface. In seven experiments, the mean ± SD Km velue for fibrinogen (i.e., molar concentration of fibrinogen required to cause 50% of the maximal rate of aggregation) was 1.58 × 10-7mol/L ± 0.68 × 10-7 mol/L. After recirculation, this value increased to 3.8 × 10-7 mol/L ± 1.94 × 10-7 mol/L (P ≤ 0.025). The maximal aggregation rate of chymotrypsin-treated platelets decreased by 40% after 2 hours of recirculation (P ≤ 0.025). The number of fibrinogen receptors on platelets, which were treated with chymotrypsin after recirculation, decreased from 41,370 ± 24,000 to 13,230 ± 10,230/platelet under the same conditions (P ≤ 0.025). The number of antigenic sites for monoclonal antibody reacting with GPIIb/GPIIIa complex of adenosine diphosphate-stimulated platelets decreased from 34,200 ± 5,940 to 19,500 ± 9,680/platelet after recirculation (P ≤ 0.025). Prostaglandin E1 (0.3 μmol/L) in the perfusion circuit preserved the ability of platelets to react with fibrinogen. In conclusion, the loss of fibrinogen receptors from the surface of platelet membranes results from the interaction of platelets with the surfaces of perfusion circuits.
UR - http://www.scopus.com/inward/record.url?scp=46549097417&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46549097417&partnerID=8YFLogxK
M3 - Article
C2 - 2984300
AN - SCOPUS:46549097417
SN - 0022-2143
VL - 105
SP - 504
EP - 513
JO - The Journal of Laboratory and Clinical Medicine
JF - The Journal of Laboratory and Clinical Medicine
IS - 4
ER -